Richard Barry, Director at Sarepta Therapeutics, Inc. (SRPT), bought 50,000 shares at $78.81 ($3.9M) on 2023-11-03, disclosed to the SEC on 2023-11-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $78.81 | 10,000 | $788K | 20.0% |
| 2 | $78.81 | 40,000 | $3.2M | 80.0% |
| Total | $78.81 avg | 50,000 | $3.9M | 100% |
| Filing → |
| SAVA | BUY | 2025-11-24 | $828K | — | Filing → |
| SAVA | BUY | 2025-11-20 | $404K | — | Filing → |
| SAVA | BUY | 2025-09-23 | $16K | — | Filing → |